1.65
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
Indaptus Therapeutics Reprices Warrants to Bolster Shareholder Support - TipRanks
Indaptus Therapeutics Signs Multiple Material Agreements - TradingView
Can Indaptus Therapeutics Inc. stock reach $100 price targetJuly 2025 Setups & Weekly High Potential Alerts - mfd.ru
Published on: 2026-02-04 21:21:37 - baoquankhu1.vn
Is Indaptus Therapeutics Inc.’s ROE strong enough2025 Top Decliners & Target Return Focused Picks - mfd.ru
Retail Trends: Why is Indaptus Therapeutics Inc stock going down2025 Earnings Impact & Free High Return Stock Watch Alerts - baoquankhu1.vn
Update Recap: Whats next for Indaptus Therapeutics Inc stock2025 EndofYear Setup & Expert Approved Trade Ideas - baoquankhu1.vn
Insider Trends: Why is Indaptus Therapeutics Inc stock going up2025 Support & Resistance & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Indaptus Therapeutics adjusts executive salaries and board member rescinds resignation - Investing.com India
Indaptus Therapeutics cuts executive pay, director stays on - TipRanks
Indaptus Therapeutics adjusts executive salaries and board member rescinds resignation By Investing.com - Investing.com South Africa
Indaptus Therapeutics Announces Board Member Decision - TradingView — Track All Markets
Analysis Recap: Is Indaptus Therapeutics Inc stock a buy or sellPortfolio Growth Summary & Low Risk High Win Rate Picks - baoquankhu1.vn
MACD Signal: Is Indaptus Therapeutics Inc stock a good pick for beginnersEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Will Indaptus Therapeutics Inc. stock recover faster than marketFit and Size Notes & lightweight options for faster days - ulpravda.ru
Indaptus Therapeutics Appoints David Natan to Board - The Globe and Mail
Indaptus Therapeutics appoints David Natan to board and audit committee By Investing.com - Investing.com Australia
Indaptus Therapeutics appoints David Natan to board and audit committee - Investing.com
Will Indaptus Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Technicals & Entry Point Confirmation Alerts - Улправда
How analysts rate Indaptus Therapeutics Inc. stock todayEarnings Risk Report & Weekly Hot Stock Watchlists - Улправда
Why did INDP stock gain 12% today? - MSN
Indaptus Therapeutics announces upcoming board leadership transition - MSN
Three Indaptus Therapeutics board members signal planned resignations By Investing.com - Investing.com Nigeria
Three Indaptus Therapeutics board members signal planned resignations - Investing.com
Indaptus Therapeutics Announces Board Resignations - TradingView — Track All Markets
Indaptus Therapeutics, Inc. (NASDAQ:INDP) Short Interest Up 25.9% in December - Defense World
Indaptus Therapeutics looks to raise $2.25M in private placement - MSN
Biotech Stocks To Keep An Eye OnDecember 24th - MarketBeat
Indaptus Therapeutics Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - marketscreener.com
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - The Globe and Mail
Indaptus Therapeutics secures $6 million investment, names new chairman By Investing.com - Investing.com Nigeria
Why Did INDP Stock Gain 12% Today? - Stocktwits
Indaptus Therapeutics stock falls after $6 million securities deal By Investing.com - Investing.com Nigeria
Indaptus Therapeutics stock falls after $6 million securities deal - Investing.com
Penny Stocks Worth Watching – December 25th - Defense World
What Does the Market Think About Indaptus Therapeutics Inc? - Benzinga
Indaptus Therapeutics Inc. (INDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Indaptus Therapeutics Inc.: Are They Ready for Takeoff? - StocksToTrade
Indaptus Therapeutics, Inc.Common Stock (Nasdaq:INDP) Stock Quote - FinancialContent
Is It Too Late to Buy INDP Stock? - timothysykes.com
Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question - ts2.tech
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):